Abeona Therapeutics announces new gene therapy facility, stock offering

Story excerpt provided by The Plain Dealer.

Written by Julie Washington.

Like a World Series team on a streak, Cleveland-based Abeona Therapeutics Inc. got hot in October.

Abeona Therapeutics is a clinical-stage biopharmaceutical company developing gene and cell therapies for life-threatening rare genetic diseases. Its strategy is to re-engineer viruses – which usually spread disease – to instead save lives.

Click here to read the complete article.

Originally published November 1, 2017.